Literature DB >> 3935571

The production of lymphokines by primary alloreactive T-cell clones: a co-ordinate analysis of 233 clones in seven lymphokine assays.

C J Sanderson, M Strath, D J Warren, A O'Garra, T B Kirkwood.   

Abstract

A total of 233 primary alloreactive T-cell clones have been tested for the production of interleukin-2 (IL-2), interleukin-3 (IL-3), immune(gamma) interferon (IFN) and granulocyte-macrophage colony-stimulating factor (CSF-2), B-cell growth factor I and II (BCGFI, BCGFII), and eosinophil differentiation factor (EDF). EDF was assayed by means of the eosinophil differentiation assay (EDA). Two principal correlations were observed: IL-3 was shown to be the major lymphokine detected in the bone marrow proliferation assay (BMPA) used to detect CSF-2, and there was a high correlation between the EDA and BCGFII. Subsequent work has suggested that this latter correlation is because a single factor is responsible for both activities. Apart from these two exceptions, and low level correlations probably due to the fact that different assays detect more than one lymphokine, there was no evidence for co-ordinate expression of lymphokines. There was a large variation in amounts of individual lymphokines produced. More clones produced multiple lymphokines than would be expected from independent control. Taken together, this pattern of regulation is consistent with the hypothesis that antigen stimulation of T cells results in the activation of all the lymphokine genes, but the amount of each produced is determined by secondary controlling mechanisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935571      PMCID: PMC1453809     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Rapid sensitive assay for interferons based on the inhibition of MM virus nucleic acid synthesis.

Authors:  P T Allen; D J Giron
Journal:  Appl Microbiol       Date:  1970-09

2.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

3.  Preparation and properties of a cytotoxic monoclonal rat anti-mouse Thy-1 antibody.

Authors:  A Chayen; R M Parkhouse
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

4.  Alloreactive cloned T cell lines. V. Differential kinetics of IL 2, CSF, and BCSF release by a cloned T amplifier cell and its variant.

Authors:  J M Ely; M B Prystowsky; L Eisenberg; J Quintans; E Goldwasser; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

5.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

6.  Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.

Authors:  M R Knapp; E Severinson-Gronowicz; J Schröder; S Strober
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

7.  Precursor frequency analysis of lymphokine-secreting alloreactive T lymphocytes. Dissociation of subsets producing interleukin 2, macrophage-activating factor, and granulocyte-macrophage colony-stimulating factor on the basis of Lyt-2 phenotype.

Authors:  A Kelso; H R Macdonald
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

8.  Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes.

Authors:  M B Prystowsky; J M Ely; D I Beller; L Eisenberg; J Goldman; M Goldman; E Goldwasser; J Ihle; J Quintans; H Remold; S N Vogel; F W Fitch
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

9.  Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.

Authors:  A L Glasebrook; F W Fitch
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

10.  Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures.

Authors:  C J Sanderson; D J Warren; M Strath
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  7 in total

1.  Coexpression of granulocyte-macrophage colony-stimulating factor, gamma interferon, and interleukins 3 and 4 is random in murine alloreactive T-lymphocyte clones.

Authors:  A Kelso; N M Gough
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  Interleukin-3 production as a sensitive measure of T-lymphocyte activation in the mouse.

Authors:  E N Dotsika; C J Sanderson
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

3.  Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin.

Authors:  J C Leung; C K Lai; Y L Chui; R T Ho; C H Chan; K N Lai
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

4.  Effect of German chamomile oil application on alleviating atopic dermatitis-like immune alterations in mice.

Authors:  Soon-Hee Lee; Yong Heo; Young-Chul Kim
Journal:  J Vet Sci       Date:  2010-03       Impact factor: 1.603

5.  Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes.

Authors:  A O'Garra; D J Warren; M Holman; A M Popham; C J Sanderson; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.

Authors:  W A Sewell; P A de Moerloose; J A Hamilton; J W Schrader; I R Mackay; M A Vadas
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

7.  Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice.

Authors:  Lin Dang; Lei He; Yan Wang; Jikui Xiong; Bingxue Bai; Yuzhen Li
Journal:  Mol Med Rep       Date:  2015-02-04       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.